TBTC Study 26 PK: Rifapentine pharmacokinetics in children receiving once weekly rifapentine and isoniazid for the treatment of latent tuberculosis infection.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2008
At a glance
- Drugs Isoniazid (Primary) ; Rifapentine (Primary)
- Indications Tuberculosis
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 24 Aug 2008 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.
- 24 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.